We are live on ! Find out more
ELOS

Syneron Medical Ltd
ELOS

Delisted

ELOS was delisted on the 14th of July, 2017.

71 hedge funds and large institutions have $331M invested in Syneron Medical Ltd in 2014 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 22 increasing their positions, 21 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more first-time investments, than exits

New positions opened: 12 | Existing positions closed: 8

18% more capital invested

Capital invested by funds: $280M → $331M (+$51.3M)

6% more funds holding

Funds holding: 6771 (+4)

5% more repeat investments, than reductions

Existing positions increased: 22 | Existing positions reduced: 21

Holders
71
Holders Change
+4
Holders Change %
+5.97%
% of All Funds
2.05%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.06%
New
12
Increased
22
Reduced
21
Closed
8
Calls
$26K
Puts
Net Calls
+$26K
Net Calls Change
+$31K
Name Holding Trade Value Shares
Change
Change in
Stake
Invesco
51
Invesco
Georgia
$181K +$19.4K +1,638 +13%
GF
52
Gabelli Funds
New York
$174K
Bank of America
53
Bank of America
North Carolina
$169K +$30.8K +2,600 +24%
ARTA
54
A.R.T. Advisors
New York
$166K +$40K +3,380 +34%
VanEck Associates
55
VanEck Associates
New York
$164K +$32.4K +2,735 +26%
CS
56
Credit Suisse
Switzerland
$146K -$30.5K -2,577 -18%
PG
57
PEAK6 Group
Illinois
$136K -$98.3K -8,300 -43%
TAM
58
Telluride Asset Management
Minnesota
$132K +$126K +10,630 New
FMT
59
First Mercantile Trust
Tennessee
$52K -$48.6K -4,100 -49%
U
60
UBS
Switzerland
$33K -$14.8K -1,251 -32%
BIT
61
BlackRock Institutional Trust
California
$9K
TRCT
62
Tower Research Capital (TRC)
New York
$6K -$28.3K -2,393 -83%
DADC
63
D.A. Davidson & Co
Montana
$6K
Royal Bank of Canada
64
Royal Bank of Canada
Ontario, Canada
$5K -$11.8K -1,000 -71%
Wells Fargo
65
Wells Fargo
California
$5K -$1.19K -100 -21%
LTFS
66
Ladenburg Thalmann Financial Services
Florida
$4K +$687 +58 +19%
AllianceBernstein
67
AllianceBernstein
Tennessee
$3K
SFSIG
68
San Francisco Sentry Investment Group
California
$3K
Citigroup
69
Citigroup
New York
$3K +$3.17K +268 New
Creative Planning
70
Creative Planning
Kansas
$1K
SAM
71
Steinberg Asset Management
New York
-$2.36M -191,672 Closed
WSA
72
Wall Street Associates
California
-$1.77M -143,700 Closed
OAM
73
Oxford Asset Management
United Kingdom
-$476K -38,698 Closed
Susquehanna International Group
74
Susquehanna International Group
Pennsylvania
-$406K -32,994 Closed
KeyBank National Association
75
KeyBank National Association
Ohio
-$271K -22,065 Closed

ELOS Hedge Fund Activity: Q1 2014 in Review

71 of the 3,462 institutional investors tracked by Wall St. Rank reported a position in Syneron Medical Ltd (ELOS) for Q1 2014, worth a combined $331M — up 18% from $280M a quarter earlier.

Buyers outnumbered sellers: 12 funds opened new ELOS positions and 8 closed out — a net gain of 4 holders — while 22 added to existing stakes and 21 trimmed.

The largest buyer was Senvest Management, opening a new position worth an estimated $43M. The largest seller was Brandes Investment Partners, cutting an estimated $6.98M.

  • 71 institutional investors held Syneron Medical Ltd (ELOS) as of Q1 2014, up from 67 in Q4 2013.
  • Funds reported $331M of Syneron Medical Ltd stock for Q1 2014, up 18% quarter-over-quarter.
  • 12 funds opened new Syneron Medical Ltd positions in Q1 2014 and 8 closed out, a net change of +4 holders.
  • The largest Syneron Medical Ltd buyer in Q1 2014 was Senvest Management, an estimated $43M added.
  • The largest Syneron Medical Ltd seller in Q1 2014 was Brandes Investment Partners, an estimated $6.98M sold.

Based on aggregated 13F filings for Q1 2014.